Intermittent preventive treatment for malaria in pregnancy in Africa: What's new, what's needed?

52Citations
Citations of this article
121Readers
Mendeley users who have this article in their library.

Abstract

Falciparum malaria is an important cause of maternal, perinatal and neonatal morbidity in high transmission settings in Sub-Saharan Africa. Intermittent preventive treatment with sulphadoxine-pyrimethamine (SP-IPT) has proven efficacious in reducing the burden of pregnancy-associated malaria but increasing levels of parasite resistance mean that the benefits of national SP-IPT programmes may soon be seriously undermined in much of the region. Hence, there is an urgent need to develop alternative drug regimens for IPT in pregnancy. This paper reviews published safety and efficacy data on various antimalarials and proposes several candidate combination regimens for assessment in phase II/III clinical trials. © 2007 Vallely et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Vallely, A., Vallely, L., Changalucha, J., Greenwood, B., & Chandramohan, D. (2007). Intermittent preventive treatment for malaria in pregnancy in Africa: What’s new, what’s needed? Malaria Journal. https://doi.org/10.1186/1475-2875-6-16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free